Roberta Celli

Via Atinense 18, IS
Pozzilli, 86077, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.

Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.

Journal: Neuropharmacology

Published: July 25, 2022

Noradrenaline and Seizures: A Perspective on the Role of Adrenergic Receptors in Limbic Seizures.

Noradrenaline and Seizures: A Perspective on the Role of Adrenergic Receptors in Limbic Seizures.

Journal: Current neuropharmacology

Published: January 29, 2022

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data.

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data.

Journal: Current neuropharmacology

Published: January 13, 2022

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data.

mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data.

Journal: Current neuropharmacology

Published: January 13, 2022

The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy.

The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy.

Journal: Current neuropharmacology

Published: October 12, 2021

Perspective on mTOR-dependent Protection in Status Epilepticus.

Perspective on mTOR-dependent Protection in Status Epilepticus.

Journal: Current neuropharmacology

Published: August 31, 2021

Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.

Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.

Journal: Neuropharmacology

Published: February 15, 2021

Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders.

Autophagy as a gateway for the effects of methamphetamine: From neurotransmitter release and synaptic plasticity to psychiatric and neurodegenerative disorders.

Journal: Progress in neurobiology

Published: December 07, 2020

Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.

Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy.

Journal: Current neuropharmacology

Published: July 09, 2020

Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmission.

Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmission.

Journal: Neuropharmacology

Published: April 17, 2020

Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.

Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.

Journal: Expert opinion on therapeutic targets

Published: February 26, 2019

Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?

Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?

Journal: International journal of molecular sciences

Published: June 01, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026